Salute e Benessere

Microsure secures €38 million to advance its microsurgical robot, MUSA-3

New and steadfast existing investors The financing round welcomes a host of new investors, including the European Innovation Council Fund (EICF), kineo, Invest-NL, and several prominent private investor groups. Microsure also acknowledges the unwavering support of key existing shareholders including deep-tech venture capital firm Innovation Industries, BOM Ventures, private investors Ten Cate Investerings Maatschappij (TCIM), Venturing Tech, Eindhoven University of Technology...
PR Newswire
04/10/2023

Fast, Reliable, Revolutionary: Unveiling 3 Key factors for the Brazil POC…

POC diagnostics offer numerous advantages compared to traditional methods, enabling patient diagnosis in various locations beyond hospitals and clinics. These locations include physician's offices, ambulances, homes, field settings, and hospitals. Among the commonly performed tests in Brazil, measuring blood glucose levels stands out as one of the most prevalent diagnostic procedures. POC testing, also referred to as bedside testing, near-patient testing, remote testing, mobile testing, or rapid…
PR Newswire
04/10/2023

Velocity opens three U.K. greenfield clinical research sites

The sites launch at a time when clinical trial activity in the U.K. has fallen in recent years. The number of patients enrolled in commercial clinical trials in the U.K. has decreased by 44% between 2017-18 and 2021-22.Velocity's growth is accelerating in the U.K. and Europe, with nine sites in total. The three new sites in the U.K. join Velocity's two existing locations in High Wycombe and North Finchley, and four in Germany. Velocity, to date, has grown via site acquisition...
Nasdaq GlobeNewswire
04/10/2023

Sensor Patch Market to Reach $56.37 Billion, Globally, by 2032 at 43.2% CAGR…

Download Research Report Sample & TOC: Download Research Report Sample & TOC: https://www.alliedmarketresearch.com/request-sample/10190 (We are providing report as per your research requirement, including the Latest Industry Insight's Evolution, Potential and COVID-19 Impact Analysis) Prime determinants of growth The global sensor patch market is driven by factors such as rise in disposable income. Moreover, surge in per capita income in healthcare industry and surge in...
PR Newswire
04/10/2023

Rejuvenate Biomed announces positive results from Phase 1b clinical trial with…

Results evaluating the impact of RJx-01 on exploratory pharmacodynamic parameters, including blood and muscle-related biomarkers, along with clinical assessments of muscle mass and strength, are anticipated later this year. Rejuvenate Biomed is gearing up to initiate a Phase 2 program focused on RJx-01 in the treatment of sarcopenia in 2024. Results evaluating the impact of RJx-01 on exploratory pharmacodynamic parameters, including blood and muscle-related biomarkers, along with clinical...
PR Newswire
04/10/2023

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense…

"We are excited for the opportunity to bring a new technology to decontaminate chemical warfare agents for application in both civilian and military markets. Our unique proprietary solution, Veriox® DECON, offers several advantages over existing decontamination products for both individual application and for mass casualty settings because it can be rapidly dispensed with standard liquid dispensing systems that will allow first responders to quickly decontaminate multiple individuals,"…
PR Newswire
04/10/2023

Sandoz enters new era as standalone global leader and European champion in…

Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz shares included in key market indicesStandalone Sandoz committed to extend leadership in stable and growing market via purpose-driven strategy with focus on sustainable accessDifferentiating investment grade credit profile and six strategic levers to drive long-term valueBasel, October 4, 2023– Sandoz, the global leader in generic and biosimilar medicines, today celebrates the...
Nasdaq GlobeNewswire
04/10/2023

Majority of newborn babies with spinal muscular atrophy (SMA) treated with…

RAINBOWFISH study met its primary endpoint with 80% of babies sitting without support for at least five seconds after 1 year of Evrysdi treatment – without treatment these babies would never be able to sit All babies were able to swallow and feed orally and none required permanent ventilation Evrysdi is the only non-invasive SMA therapy and is approved in over 100 countries with more than 11,000 patients treated globallyBasel, 04 October 2023 - Roche (SIX: RO, ROG; OTCQX:...
Nasdaq GlobeNewswire
04/10/2023

Press Release: Sanofi and Teva announce exclusive collaboration to deliver…

Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentTEV'574, a novel anti-TL1A therapy, is being developed to treat ulcerative colitis and Crohn's diseaseCollaboration supports Sanofi's immunology strategy of exploring novel mechanisms of action for chronic inflammatory diseasesCollaboration leverages the innovative R&D and commercial expertise of both companiesParis, France and Parsippany, New Jersey,October 4 , 2023...
Nasdaq GlobeNewswire
04/10/2023

Press Release: Sanofi and Teva announce exclusive collaboration to deliver…

Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentTEV'574, a novel anti-TL1A therapy, is being developed to treat ulcerative colitis and Crohn's diseaseCollaboration supports Sanofi's immunology strategy of exploring novel mechanisms of action for chronic inflammatory diseasesCollaboration leverages the innovative R&D and commercial expertise of both companiesParis, France and Parsippany, New Jersey,...
Nasdaq GlobeNewswire
04/10/2023

Novartis executes Sandoz Spin-off, completing strategic transformation into a…

Ad hoc announcement pursuant to Art. 53 LR Novartis executes separation of the Sandoz business to create an independent company by way of a 100% Spin-offShares of Sandoz will be listed and commence trading today on the SIX Swiss ExchangeSpin-off allows shareholders to benefit from a Novartis with capital and management attention fully focused on innovative medicinesNovartis pipeline one of the industry's most competitive, focused on key next-generation platforms and four core...
Nasdaq GlobeNewswire
04/10/2023

Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis…

Key Takeaways from the Narcolepsy Market Report Key Takeaways from the Narcolepsy Market Report Discover which therapies are expected to grab the major narcolepsy market share @Narcolepsy Market Report Narcolepsy Overview Narcolepsy is a persistent neurological condition that disrupts the regulation of sleep and wakefulness. Individuals with narcolepsy frequently encounter excessive daytime drowsiness and abrupt, uncontrollable bouts of falling asleep at any time of the day...
PR Newswire
03/10/2023

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 09/30/202355,583,76861,519,946About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T...
Nasdaq GlobeNewswire
03/10/2023

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the…

"COVID-19 is once again on the rise with infections and hospitalizations increasing, so it's important that individuals get vaccinated to protect themselves and their loved ones," said John C. Jacobs, President and Chief Executive Officer, Novavax. "Novavax's authorization today means people will now have the choice of a protein-based non-MRNA option to help protect themselves against COVID-19, which is now the fourth leading cause of death in the U.S. In the coming days…
PR Newswire
03/10/2023

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

PHAXIAM Therapeutics and Vetophage AnnounceStrategic ResearchCollaboration Strategic research partnership between PHAXIAM Therapeutics and Vetophage, a biotechnology company specialized in veterinary phage therapyCombining expertise in the research of new phages and phage endolysins that could be applied to human healthExclusive phage and endolysin licensing options in human health for PHAXIAM Therapeutics Lyon (France) and Cambridge...
Nasdaq GlobeNewswire
03/10/2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – October 3 , 2023 – 7 .00PM CETOxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on October 3, 2023,...
Nasdaq GlobeNewswire
03/10/2023

Ipsen updates on QM-1114 regulatory process

PARIS, FRANCE,3 October 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its partner Galderma has confirmed receipt from the FDA of a Complete Response Letter related to its Biologics License Application for liquid botulinum toxin type A (QM-1114), noting certain deficiencies related to chemical, manufacturing and controls (CMC) processes. Furthermore, on 28 September 2023, the Arbitral Tribunal of the International Chamber of Commerce (ICC) issued a final decision on...
Nasdaq GlobeNewswire
03/10/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode)IPSEN549300M6SGDPB4Z94P1125/09/2023FR001025915084123.40AQEUIPSEN549300M6SGDPB4Z94P11...
Nasdaq GlobeNewswire
03/10/2023

Healthcare Analytics Market to Garner a Valuation of USD 139.34 Billion by 2030…

Explore more about this report - Request for Sample and Scope of the Study @ https://www.kingsresearch.com/request-sample/healthcare-analytics-market-185 Explore more about this report - Request for Sample and Scope of the Study @https://www.kingsresearch.com/request-sample/healthcare-analytics-market-185 Competitive Landscape Key participants in the global healthcare analytics market are emphasizing acquisitions as a primary approach for expanding their businesses. For...
PR Newswire
03/10/2023

Transactions in connection with and conclusion of share buy-back program

Company announcement no. 50 - 233 October 2023 Transactions in connection with and conclusion of share buy-back program On 3 August 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 38 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the...
Nasdaq GlobeNewswire
03/10/2023

Cardiac Safety Services Market worth $1,282 million | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174488627 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174488627 Browse in-depth TOC on "Cardiac Safety Services Market" 149 - Tables 43 - Figure 205 - Pages Cardiac Safety Services Market Scope: The integrated services segment accounted for the largest share, by type in the cardiac safety services market in 2022. By type,...
PR Newswire
03/10/2023

Decorated Apparel Market to Hit US$ 99 billion as Key Companies Line up for…

The global decorated apparel market registered an astonishing CAGR of 14.6% in the historical period between 2018 and 2022. The growing popularity of screen and digital printing on garments is a key factor driving market development. The global decorated apparel market registered an astonishing CAGR of14.6%in the historical period between 2018 and 2022. The growing popularity of screen and digital printing on garments is a key factor driving market development. Decorated Apparel Market...
PR Newswire
03/10/2023

How to Lose Weight Fast and Improve Your Mental Health at Gowalking.com

One of Gowalking.com's standout features is its walking news aggregation section, akin to the Drudge Reports. Here, you can stay updated with the latest walking news articles that delve into the numerous fitness and mental health benefits of walking. Articles cover topics such as walking workouts, walking for exercise, walking for health, and exercise walking for fitness and fun. One of Gowalking.com's standout features is its walking news aggregation section, akin to the Drudge Reports...
PR Newswire
03/10/2023

Fierce Names Dr. Dennis Wall, Founder of Cognoa, as One of its Fierce 50…

Dr. Wall is an innovative scientist who has focused his career on supporting developing children and their families by inventing pioneering solutions and making them widely accessible. Dr. Wall received his PhD from University of California, Berkeley, and fellowship in Computational Genetics from Stanford. As a professor for the last 20 years at Stanford and Harvard Medical Schools, his work has focused on building novel artificial intelligence methods within digital technologies and mobile…
PR Newswire
03/10/2023
Altri  Comunicati